Corcept Therapeutics Appoints Joshua M. Murray to Board of Directors
June 10, 2021 at 05:00 pm IST
Corcept Therapeutics Incorporated announced that Joshua M. Murray has joined the company’s Board of Directors. Mr. Murray is currently Senior Vice President, Finance, Strategy and Investor Relations at Orca Bio, a privately held biotechnology company developing allogeneic cell therapies in blood, immune, and genetic diseases. Prior to joining Orca, Mr. Murray spent 15 years at Goldman Sachs, most recently as a Managing Director in the Investment Banking Division, where he advised a wide array of biotechnology and life sciences companies.